SCINAI IMMUNOTHERAPEUTICS LTD. Operating Expense
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Operating Expense of ILS 16.09 million for the 3-month period ending 2020-06-30, per its 6-K filed 2020-10-02.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2020-10-02
- SCINAI IMMUNOTHERAPEUTICS LTD. operating expense for the quarter ending 2020-06-30 was 16.09M ILS, a 18.30% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. operating expense for the quarter ending 2019-06-30 was 19.69M ILS.
ILS
| Period end | Operating Expense 3 month | Operating Expense 6 month | Operating Expense 12 month |
|---|---|---|---|
| 2020-06-30 | 16.09M ILS 6-K · filed 2020-10-02 | 36.14M ILS 6-K · filed 2020-10-02 | |
| 2019-12-31 | 78.35M ILS 6-K · filed 2020-10-02 | ||
| 2019-06-30 | 19.69M ILS 6-K · filed 2020-10-02 | 26.86M ILS 6-K · filed 2020-10-02 | |
| 2018-12-31 | 77.07M ILS 20-F · filed 2020-06-12 | ||
| 2017-12-31 | 23.66M ILS 20-F · filed 2020-06-12 | ||
| 2016-12-31 | 11.90M ILS 20-F · filed 2019-04-30 | ||
| 2015-12-31 | 11.30M ILS 20-F · filed 2018-04-30 |
USD
| Period end | Operating Expense 12 month |
|---|---|
| 2017-12-31 | $6.82M 20-F · filed 2018-04-30 |